01.23.24 -- Adapting With Automation: A Guide For The Modern Lab

As highly potent active pharmaceutical ingredients become increasingly common across the industry, it is critical to work with partners who use a risk-based approach to ensure safety and quality.

The success of CGTs hinges upon adherence to specific logistics protocols. Learn how the integration of AI in the pharma supply chain is poised to enhance visibility, efficiency, and compliance.

The simultaneous spray drying of multiple ingredients is a powerful technique for making inhaled products with multiple actives. Examine how novel techniques can make these products a reality.

Explore the challenges faced in administering highly viscous biologics to patients via subcutaneous injection and how new special thin-wall needles are able to tackle them.

Read about three studies that assess a product that aims to address the unmet needs around the development of subcutaneous drug therapies for chronic disease treatment.

Analyze a chromatography system's performance during column qualification and protein A purification of a monoclonal antibody (mAb) from clarified cell culture fluid (CCCF).

Container closure integrity (CCI) test methods aim to find manufacturing errors and mitigate risk to patient safety. Here, we delve deeper into the CCI testing of biologics and effective test methods.

Understanding the obstacles you may face during bioconjugate development, as well as the tools available to help overcome them, can help streamline your product’s path to market.

Learn how a CDMO helps biopharma organizations predict and mediate technical transfer risks before they become costly, time-consuming problems.

Discover a protein L affinity chromatography resin that is well suited for use in biomanufacturing and offers increased binding capacities compared to other resins.

Ensuring regulatory compliance is paramount for a CDMO to meet manufacturing standards, warrant patient safety, and maintain its reputation.